Will Amylyx’s ALS Drug Benefit From US FDA’s Aduhelm Experience?

 
• By Derrick Gingery
Astrocyte and blood vessel
The second advisory committee meeting will offer another opportunity for the public to learn about FDA's thinking on AMX0035. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers